AK-FLUOR 25%
LOE Approachingfluorescein
NDAINTRAVENOUSINJECTABLE
Approved
Aug 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Mechanism of Action
465 to 490 nm and fluoresces, i.e., emits light at wavelengths of 520 to 530 nm. Thus, the hydrocarbon is excited by blue light and emits light that appears yellowish green. Following intravenous injection of fluorescein sodium in an aqueous solution, the unbound fraction of the fluorescein can be…
Clinical Trials (3)
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Started Nov 2025
10 enrolled
RetinopathyRetinal Vein OcclusionDiabetic Retinopathy+1 more
A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
Started May 2022
Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept
Started Jan 2017
65 enrolled
Retinal Vein Occlusion